Methods for treating neuroblastoma
US10561651B2 · kind B2 · utility
3Cited by
19References
8Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jul 31, 2018 |
| Grant date | Feb 18, 2020 |
| Priority date | — |
| Expiry date | Jul 31, 2038 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods of treating neuroblastoma associated with a deregulated protein kinase activity are disclosed. The treatment may include administration of substituted indazole derivatives of formula (I) or formula 2.(I) and pharmaceutically acceptable salts therefor, as degined in the specification.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.